Culture of Pharmaceutical Quality: Improving Quality Management System

Introduction Regulatory observations of breaches in the assurance of data integrity are among the most serious allegations of CGMP violations. When such observations are followed by a Warning Letter and/or Import Alert it indicates that regulators have lost trust in company’s quality management sy...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter and WEBINAR UPDATES

We will not sell or give your information to a third party. See our Privacy Policy